Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CES2 | O00748 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3956653 | 0.77 | KMT2A (0.48) | KMT2AMEN1ATMALDH1A1CES2 | |
| SCHEMBL10351264 | 0.74 | KMT2A (0.46) | KMT2AMEN1ALDH1A1CES2CES1 | |
| SCHEMBL5642109 | 0.73 | CES2 (0.43) | KMT2AMEN1ATMALDH1A1CES2 | |
| SCHEMBL7087951 | 0.72 | KMT2A (0.45) | KMT2AMEN1ATMALDH1A1CES2 | |
| SCHEMBL27601005 | 0.72 | KMT2A (0.45) | KMT2AMEN1ATMALDH1A1CES2 | |
| SCHEMBL25137339 | 0.72 | ALDH1A1 (0.47) | KMT2AMEN1ALDH1A1CES2CES1 | |
| SCHEMBL27498167 | 0.72 | BLM (0.46) | KMT2AMEN1ALDH1A1CES2CES1 | |
| SCHEMBL2320794 | 0.72 | ALDH1A1 (0.47) | KMT2AMEN1ALDH1A1MAPTLMNA | |
| SCHEMBL812709 | 0.72 | KMT2A (0.56) | KMT2AMEN1ALDH1A1CES2CES1 | |
| SCHEMBL1668498 | 0.72 | F2 (0.46) | KMT2AMEN1ALDH1A1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5214116-A | Acrylic polymers with thioester group, lenses, optical fibers, optical recording media | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1993-05-25 | — | — | US | claimed |
| US-7229751-B2 | Silver salt photothermographic dry imaging material and image forming method using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-06-12 | — | — | US | disclosed |
| US-7211373-B2 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
| US-7183296-B2 | Anti-HIV pyrazole derivatives | ROCHE PALO ALTO LLC (US) | 2007-02-27 | — | — | US | disclosed |
| US-7083908-B2 | Photothermographic material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-08-01 | — | — | US | disclosed |
| EP-1300726-B1 | Photothermographic material comprising fragmentable electron donor | FUJI PHOTO FILM CO LTD (JP) | 2005-12-21 | — | — | EP | disclosed |
| US-6949332-B2 | Silver halide emulsion and method of preparing the same | FUJI PHOTO FILM CO., LTD. (JP) | 2005-09-27 | — | — | US | disclosed |
| US-20050158675-A9 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2005-07-21 | — | — | US | disclosed |
| US-20050147931-A1 | Process for manufacturing a photothermographic material | FUJI PHOTO FILM CO., LTD. | 2005-07-07 | — | — | US | disclosed |
| US-20050136366-A1 | Silver salt photothermographic dry imaging material and image forming method using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-06-23 | — | — | US | disclosed |
| US-20030203329-A1 | Silver halide photosensitive material | FUJI PHOTO FILM CO., LTD. | 2003-10-30 | — | — | US | disclosed |
| US-20030194638-A1 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1326843-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. Hoffmann-La Roche AG (CH) | 2003-07-16 | — | — | EP | disclosed |
| EP-1300726-A1 | Photothermographic material comprising fragmentable electron donor | FUJI PHOTO FILM CO., LTD. (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20030018197-A1 | Anti-HIV pyrazole derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-23 | — | — | US | disclosed |
| WO-2002030907-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-04-18 | — | — | WO | disclosed |
| EP-0382477-B1 | Resin having a high refractive index | TOKUYAMA CORP (JP) | 1995-04-19 | — | — | EP | disclosed |
| US-5214116-A | Acrylic polymers with thioester group, lenses, optical fibers, optical recording media | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0382477-A1 | Resin having a high refractive index | TOKUYAMA CORPORATION (JP) | 1990-08-16 | — | — | EP | disclosed |
| EP-0355583-A2 | Cardiotonics | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018197-A1 | Anti-HIV pyrazole derivatives | CYP51A1, TYMP, POLRMT | KMT2A 3464/4885MEN1 4862/4885ATM 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.